Search

New Drug Sofosbuvir can Reduce Transplant and Mortality Rates in Patients With Hepatitis C

NEW DRUG SOFOSBUVIR CAN REDUCE TRANSPLANT AND MORTALITY RATES IN PATIENTS WITH HEPATITIS C

The new drug called sofosbuvir reduced the progression of advanced liver disease in hepatitis C patients. Patients with cirrhosis can...

FDA Approves Drugs for Hepatitis C Infected Older Children

FDA APPROVES DRUGS FOR HEPATITIS C INFECTED OLDER CHILDREN

The US FDA has approved the use of sofosbuvir and sofusbuvir-ledipasvir combination for hepatitis C in children over 12 years of age.